This Report to Congress examines the critical role that insulin plays in the treatment of diabetes, reviews evidence on how insulin affordability affects adherence to insulin treatment and affects downstream health consequences, and describes policy efforts to improve the affordability of insulin. The Report also analyzes total health expenditures and out-of-pocket costs for patients with diabetes who use insulin, as well as the potential savings that may accrue from policies designed to improve insulin affordability, including provisions from the Inflation Reduction Act.
*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Kenneth Finegold, (202) 557-9553, Kenneth.Finegold@hhs.gov. Content will be updated pending the outcome of the Section 508 review.